AbbVie | ABBV - Equity Capital And Reserves

Stock Price
228.51
Daily Change
-0.97 -0.42%
Monthly
3.51%
Yearly
11.94%
Q1 Forecast
217.84

AbbVie reported $-3.27B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Abbott USD 52.13B 1.3B Dec/2025
ALKERMES USD 1.73B 108.85M Sep/2025
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.09B 30.29M Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Coherus Biosciences USD 87.77M 32.05M Sep/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
J&J USD 78.47B 0 Sep/2025
Medtronic USD 48.86B 964M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Neurocrine Biosciences USD 3.25B 249.5M Dec/2025
Novartis USD 44.75B 2.7B Sep/2025
Pacira USD 727.21M 30.55M Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
United Therapeutics USD 6.59B 583.4M Sep/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025